- France
- /
- Semiconductors
- /
- ENXTPA:MEMS
Spotlight On 3 Promising Penny Stocks With Market Caps Over US$20M
Reviewed by Simply Wall St
Global markets have recently experienced a surge, with major indices like the Dow Jones Industrial Average and S&P 500 reaching record highs, driven by domestic policy developments and geopolitical events. Amidst this backdrop, penny stocks remain an intriguing investment area despite being considered somewhat outdated. These smaller or newer companies can offer unique growth opportunities when supported by strong financials, making them appealing for investors looking for under-the-radar potential in today's market landscape.
Top 10 Penny Stocks
Name | Share Price | Market Cap | Financial Health Rating |
DXN Holdings Bhd (KLSE:DXN) | MYR0.515 | MYR2.56B | ★★★★★★ |
Tristel (AIM:TSTL) | £3.65 | £177.65M | ★★★★★★ |
Embark Early Education (ASX:EVO) | A$0.785 | A$144.03M | ★★★★☆☆ |
Hil Industries Berhad (KLSE:HIL) | MYR0.90 | MYR298.75M | ★★★★★★ |
ME Group International (LSE:MEGP) | £2.16 | £828.88M | ★★★★★★ |
Lever Style (SEHK:1346) | HK$0.87 | HK$552.27M | ★★★★★★ |
Bosideng International Holdings (SEHK:3998) | HK$4.05 | HK$44.6B | ★★★★★★ |
LaserBond (ASX:LBL) | A$0.56 | A$65.64M | ★★★★★★ |
Datasonic Group Berhad (KLSE:DSONIC) | MYR0.405 | MYR1.13B | ★★★★★★ |
Secure Trust Bank (LSE:STB) | £3.53 | £67.51M | ★★★★☆☆ |
Click here to see the full list of 5,693 stocks from our Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Altia Consultores (BME:ALC)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Altia Consultores, S.A. operates in the information and communication technologies (ICT) sector both in Spain and internationally, with a market cap of €318.48 million.
Operations: The company's revenue is primarily derived from its Altia segment (€122.39 million), followed by Noesis (€72.98 million), Bilbomatics (€57.48 million), Exis (€8.98 million), and Chile (€1.43 million).
Market Cap: €318.48M
Altia Consultores, S.A. operates in the ICT sector with a market cap of €318.48 million and has shown stable financial health, as its short-term assets exceed both short and long-term liabilities. The company's earnings have grown significantly by 22.6% per year over the past five years, although recent growth has slowed to 9.9%, aligning with industry averages. Despite high-quality earnings and well-covered interest payments on debt, Altia's net profit margins have slightly declined from last year. Its share price remains volatile, yet shareholders haven't faced significant dilution recently, maintaining investor confidence amidst fluctuating returns.
- Navigate through the intricacies of Altia Consultores with our comprehensive balance sheet health report here.
- Understand Altia Consultores' track record by examining our performance history report.
MEMSCAP (ENXTPA:MEMS)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: MEMSCAP, S.A. offers micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical, and biomedical markets globally with a market cap of €27.50 million.
Operations: There are no specific revenue segments reported for MEMSCAP.
Market Cap: €27.5M
MEMSCAP, S.A., with a market cap of €27.50 million, has demonstrated earnings growth of 25.5% over the past year, surpassing the semiconductor industry's decline. However, recent financial results show a decrease in both sales and net income compared to last year. The company maintains strong financial health with short-term assets exceeding liabilities and reduced debt levels over five years. Despite stable weekly volatility and satisfactory debt coverage by operating cash flow, MEMSCAP's share price remains highly volatile, and shareholders experienced dilution last year. Trading significantly below estimated fair value may attract value-focused investors despite low return on equity.
- Dive into the specifics of MEMSCAP here with our thorough balance sheet health report.
- Understand MEMSCAP's earnings outlook by examining our growth report.
Beijing Lier High-temperature MaterialsLtd (SZSE:002392)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Beijing Lier High-temperature Materials Co., Ltd. specializes in the production of high-temperature resistant materials and has a market cap of CN¥5.57 billion.
Operations: No specific revenue segments are reported for Beijing Lier High-temperature Materials Co., Ltd.
Market Cap: CN¥5.57B
Beijing Lier High-temperature Materials Co., Ltd. has shown robust earnings growth of 48.5% over the past year, outperforming the Metals and Mining industry average. Despite a low return on equity of 7.4%, the company maintains financial stability with short-term assets exceeding both its short and long-term liabilities, and it holds more cash than total debt. Recent buyback activities suggest confidence in its stock value, although dividends are not well covered by free cash flow. Trading at a price-to-earnings ratio of 13.9x below the CN market average indicates potential value for investors seeking opportunities in this sector.
- Unlock comprehensive insights into our analysis of Beijing Lier High-temperature MaterialsLtd stock in this financial health report.
- Review our growth performance report to gain insights into Beijing Lier High-temperature MaterialsLtd's future.
Summing It All Up
- Unlock our comprehensive list of 5,693 Penny Stocks by clicking here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:MEMS
MEMSCAP
Provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical, and biomedical markets worldwide.
Flawless balance sheet with reasonable growth potential.